Health Catalyst to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Health Catalyst (NASDAQ: HCAT), a leading healthcare data and analytics technology provider, has announced its participation in three major upcoming investor conferences in September 2025:
- Cantor Global Healthcare Conference in New York on September 3, 2025 at 9:10 AM ET
- Wells Fargo Healthcare Conference in Boston on September 4, 2025 at 1:30 PM ET
- Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 9, 2025 at 11:30 AM ET
Senior management, including CEO Dan Burton, CFO Jason Alger, and SVP of Finance Matt Hopper, will participate in fireside chats at these events. Webcasts will be available on the company's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, HCAT gained 7.19%, reflecting a notable positive market reaction. This price movement added approximately $15M to the company's valuation, bringing the market cap to $231M at that time.
Data tracked by StockTitan Argus on the day of publication.
SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:
- The Cantor Global Healthcare Conference, being held in New York, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, September 3, 2025 at 9:10am ET.
- The Wells Fargo Healthcare Conference, being held in Boston, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of Finance and Head of Investor Relations, on Thursday, September 4, 2025 at 1:30pm ET. The webcast link will be available online at https://ir.healthcatalyst.com.
- The Morgan Stanley 23rd Annual Global Healthcare Conference, being held in New York, including a fireside chat with Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Tuesday, September 9, 2025 at 11:30am ET.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.
Health Catalyst Investor Relations Contact:
Matt Hopper
SVP of Finance and Head of Investor Relations
+1 (855) 309-6800
ir@healthcatalyst.com
Health Catalyst Media Contact:
Kathryn Mykleseth
Director of PR and Communications
media@healthcatalyst.com